Drapime TZ 1.125gm Injection
Marketer
Drams Healthcare
Salt Composition
Cefepime (1000mg) + Tazobactum (125mg)
Overview Drapime TZ 1.125gm Injection
This injectable medication, Drapime TZ 1.125gm, combines two antibiotics to combat diverse bacterial infections. Its mechanism involves inhibiting microbial proliferation. Administration must be overseen by a medical practitioner; strict adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Potential side effects include nausea, vomiting, diarrhea, and skin rashes; injection site reactions such as redness, swelling, and soreness may also occur, typically resolving spontaneously. Severe or worsening side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, swelling, respiratory distress) demand prompt medical help. Prior to use, inform your doctor of all current medications and health conditions. Pregnant or lactating individuals should consult their physician before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid driving if drowsiness or dizziness occurs.
Uses of Drapime TZ 1.125gm Injection
Infections caused by bacteria
Major Benefits of Drapime TZ 1.125gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Drapime TZ 1.125gm Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Drapime TZ 1.125gm Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Drapime TZ 1.125gm Injection works:
Drapime TZ 1.125gm Injection unites Cefepime, an antibiotic, with Tazobactum, a beta-lactamase inhibitor. Cefepime's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counteracts bacterial enzymes that would otherwise neutralize Cefepime, thereby bolstering Cefepime's efficacy and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining alcohol and Drapime TZ 1.125gm Injection. Seek medical advice before doing so.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Drapime TZ (1.125 gm) is typically deemed safe for pregnant individuals. Preclinical trials using animals have revealed minimal or no harmful consequences to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Drapime TZ 1.125gm Injection poses minimal risk during lactation. Research in humans indicates negligible transfer of the medication into breast milk, presenting no known danger to the infant.
DrivingUNSAFE
Following administration of Drapime TZ 1.125gm Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Individuals with impaired kidney function should use Drapime TZ 1.125gm Injection cautiously. The dosage of Drapime TZ 1.125gm Injection might require modification. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
In patients with liver impairment, Drapime TZ 1.125gm Injection appears to be well-tolerated. Current evidence indicates dose modification may not be necessary, however, physician consultation is recommended.
What if you forget to take Drapime TZ 1.125gm Injection :
Omitting a scheduled dose of Drapime TZ 1.125gm Injection necessitates contacting your physician.
Facts to Know About Drapime TZ 1.125gm Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Type of Therapy | Antimicrobials |
3,018 People bought this recently